$DJI 0.59% NDX 0.99% SPX 0.49% VIX 9.04% News *
Sun, Sep 22 2:30pm

GALT $3.73 0.04 (1.08%)
Galectin Therapeutics Inc | NASDAQ

GALT Profile

Market Cap 200.00 Million
GALT Description

Galectin Therapeutics Inc is a biotechnology company. The company is focused on discovery and development. It is engaged in galectin science and drug development to create new therapies to improve the lives of patients with chronic liver and skin diseases and cancer. Drug candidates based on carbohydrate technology target galectin proteins, which are key mediators of biologic and pathologic function. Galectin Therapeutics is pursuing therapies for indications in which galectins have a demonstrated role in the pathogenesis of directly involved in multiple inflammatory, fibrotic, and malignant diseases. The lead development program is in non-alcoholic steatohepatitis (NASH) with cirrhosis, the most advanced form of NASH-related fibrosis.


Visit Website

GALT Earnings

EPS -0.06 P/E Ratio 0.00
Previous Fri, May 10, 2019
Latest Fri, Aug 9, 2019 (44 days ago) +5.97%

GALT Dividend

Yield --
Ex-Date --
Pay Date --
History --

GALT Charts

$2.97
1 Year
$6.85
Aug 27, 2019
Sep 24, 2018



Symbol Price Day Δ YTD Δ
GALT $3.73 1.08% -3.37%

Trending Fri, Sep 20, 2019

This list of trending stocks may change throughout the trading day.


JPM 118.90 -0.40% JNJ 131.65 +1.18% WMT 116.98 -0.11% XOM 72.08 -0.35% PG 122.24 +0.28% MA 271.17 -1.72% MRK 85.16 +1.42% PFE 36.69 +0.49% ORCL 53.47 +0.19% CHL 41.02 -0.73% NKE 86.68 -1.16% CRM 155.20 +1.04% BP 38.99 +0.78% NFLX 270.75 -5.53% PYPL 104.64 -1.39% ABBV 72.39 +1.00% QCOM 76.44 -2.29% CVS 64.30 +1.05% BMY 50.57 +1.00% CME 211.15 -0.38% BDX 253.55 -1.10% TJX 54.81 -2.92% COP 60.82 +1.42% BX 52.89 -0.02% CI 161.38 -2.02% PNC 140.88 -0.09% GM 37.37 -1.09% RTN 194.93 -2.21% BAM 53.90 -0.48% WBA 55.00 +0.79% PLD 84.35 -0.79% SLB 37.30 -1.22% AMAT 50.96 -1.39% HMC 26.68 +0.11% LVS 56.33 -2.17% JD 30.94 -0.35% BAX 87.40 -0.07% ING 10.69 +1.04% ROST 104.75 -3.55% AABA 70.51 +0.11% CM 83.68 -0.17% ALL 107.92 -0.41% YUM 112.30 -1.58% EBAY 40.36 -0.10% IWM 155.43 -0.21% PEG 61.80 +0.13% REGN 295.87 +3.40% NXPI 104.80 -3.29% IR 123.15 -0.66% CS 12.82 -0.31% ED 92.40 +0.57% XLNX 96.55 -6.82% XLF 28.08 -1.09% CMI 161.57 -0.28% FE 47.39 -1.50% XLK 80.26 -1.47% PCAR 70.32 -0.04% SPOT 120.70 -2.97% ADM 40.90 +0.00% MSCI 225.73 -4.10% CNC 46.39 -0.13% WDC 60.68 -3.14% ABC 85.12 +0.58% DHI 51.58 +1.40% DISH 34.54 -2.54% CBS 41.88 -1.20% PFG 56.56 -0.60% SYMC 23.88 -0.42% LYV 67.39 -0.44% TWLO 114.22 -0.77% EMB 114.47 +0.45% CAG 29.81 +0.51% KSU 132.04 -0.20% WYNN 108.75 -2.45% TSCO 90.39 -1.84% W 122.75 -4.60% XRAY 51.13 +2.46% WB 47.83 -3.20% FTI 24.39 +1.63% XLI 77.81 -1.16% VIAB 24.94 -1.07% MRO 13.18 +1.07% RE 264.50 +0.84% AES 16.09 +0.88% NRG 39.07 +0.70% BAH 70.18 -3.24% PKI 86.56 +0.53% UAA 19.66 -2.72% PHM 35.68 +0.62% UA 17.98 -2.39% CY 23.24 -0.04% AU 20.22 +2.85% KSS 49.02 +0.45% ZION 44.51 -0.16% AIZ 126.64 +0.32% AIV 51.12 -0.74% IVE 119.99 -0.40% FIVE 126.54 -1.51% XLP 60.32 -0.90% XLU 63.87 -0.37% GPS 17.19 -2.00% TLT 141.89 +1.32% ESLT 160.50 -0.85% LPLA 84.12 -0.18% SBNY 119.65 -1.38% TTM 9.54 +8.53% TRIP 39.13 -2.88% FXI 40.54 -0.37% LEG 40.81 -1.14% M 15.41 -1.97% TFSL 18.05 -0.22% TDOC 72.15 +4.98% PEN 147.90 +0.06% TQQQ 63.42 -3.15% KBE 43.56 -0.86% LM 38.34 -1.87% STRA 147.01 -7.39% FIVN 58.43 +0.74% GT 13.82 +2.14% SINA 42.56 -2.34% EBS 51.06 -1.90% THC 25.33 +0.64% PSEC 6.68 +1.37% PENN 19.76 +0.00% FIZZ 45.04 -2.49% DIOD 39.86 -0.20% LADR 17.22 -0.35% TELL 8.68 +1.17% IRBT 60.07 -2.13% EWU 31.56 -0.41% GSHD 49.19 +5.81% KALU 97.28 -0.49% STNG 28.21 -0.32% PRAA 35.22 +1.65% CORT 14.09 +2.55% DENN 23.27 +1.00% STBA 37.07 -0.24% GCI 10.93 +0.83% GES 17.48 -1.58% UFCS 46.26 -1.74% SM 10.83 +3.93% LNN 94.05 +0.32% SPPI 8.95 -5.29%

Advertisers

Symbol Surfing

How can we make Symbol Surfing better?

info@symbolsurfing.com

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.



©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy